Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glucocorticoids induce differentiation and chemoresistance in ovarian cancer by promoting ROR1-mediated stemness
Hanna Karvonen, Mariliina Arjama, Laura Kaleva, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 9
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

The WNT/ROR Pathway in Cancer: From Signaling to Therapeutic Intervention
Kerstin Menck, Saskia Heinrichs, Cornelia Baden, et al.
Cells (2021) Vol. 10, Iss. 1, pp. 142-142
Open Access | Times Cited: 93
Synergistic effects of flavonoids and paclitaxel in cancer treatment: a systematic review
Solmaz Asnaashari, Elham Amjad, Babak Sokouti
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 34
The cancer-immune dialogue in the context of stress
Yuting Ma, Guido Kroemer
Nature reviews. Immunology (2023) Vol. 24, Iss. 4, pp. 264-281
Closed Access | Times Cited: 34
The signaling pathways activated by ROR1 in cancer
María Josefina Quezada, Pablo Lopez‐Bergami
Cellular Signalling (2023) Vol. 104, pp. 110588-110588
Closed Access | Times Cited: 21
An Overview of Ovarian Cancer: The Role of Cancer Stem Cells in Chemoresistance and a Precision Medicine Approach Targeting the Wnt Pathway with the Antagonist sFRP4
Lavanya Varier, Sumati Sundaram, Naisarg Gamit, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1275-1275
Open Access | Times Cited: 19
Exploring the Wnt Pathway as a Therapeutic Target for Prostate Cancer
Sarah Koushyar, Valérie S. Méniel, Toby J. Phesse, et al.
Biomolecules (2022) Vol. 12, Iss. 2, pp. 309-309
Open Access | Times Cited: 23
Knockdown of NR3C1 inhibits the proliferation and migration of clear cell renal cell carcinoma through activating endoplasmic reticulum stress–mitophagy
M. Yan, Jinhua Wang, Haojie Wang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Prognostic Significance of Glucocorticoid Receptor Expression in Cancer: A Systematic Review and Meta-Analysis
Noor Bakour, Frank Moriarty, Gillian Moore, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1649-1649
Open Access | Times Cited: 28
Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients
Gudmundur Johannsson, Philippe Touraine, Ulla Feldt‐Rasmussen, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 7, pp. 1906-1919
Open Access | Times Cited: 20
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
Mary L. Disis, Sarah F. Adams, Jyoti Bajpai, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006624-e006624
Open Access | Times Cited: 12
Effects of anesthetics on development of gynecological cancer
Yufeng Cheng, Y. Wu, Lingzhong Xu
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
The Ror-Family Receptors in Development, Tissue Regeneration and Age-Related Disease
Mitsuharu Endo, Koki Kamizaki, Yasuhiro Minami
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 17
Actin-related protein 2/3 complex subunit 1B promotes ovarian cancer progression by regulating the AKT/PI3K/mTOR signaling pathway
Miao Ke, Huimin Zhu, Yu Lin, et al.
Journal of Translational Internal Medicine (2024) Vol. 12, Iss. 4, pp. 406-423
Closed Access | Times Cited: 3
Evaluating Targeted Therapies in Ovarian Cancer Metabolism: Novel Role for PCSK9 and Second Generation mTOR Inhibitors
Dafne Jacome Sanz, Juuli Raivola, Hanna Karvonen, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3727-3727
Open Access | Times Cited: 21
Survival Mechanisms of Metastatic Melanoma Cells: The Link between Glucocorticoids and the Nrf2-Dependent Antioxidant Defense System
Elena Obrador, Rosario Salvador‐Palmer, Rafael López‐Blanch, et al.
Cells (2023) Vol. 12, Iss. 3, pp. 418-418
Open Access | Times Cited: 8
Characterization of Immunogenicity of Malignant Cells with Stemness in Intrahepatic Cholangiocarcinoma by Single-Cell RNA Sequencing
Jing Bian, Jianyang Fu, Xin Wang, et al.
Stem Cells International (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 11
Is the glucocorticoid receptor a key player in prostate cancer?: A literature review
Minas Sakellakis, Laura Jacqueline Flores
Medicine (2022) Vol. 101, Iss. 29, pp. e29716-e29716
Open Access | Times Cited: 11
The Efficacy and Safety of Glucocorticoid on Periarticular Infiltration Analgesia in Total Knee Arthroplasty: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Ziquan Li, Li Zeng, Kai-Yuan Cheng, et al.
The Journal of Arthroplasty (2021) Vol. 36, Iss. 9, pp. 3340-3350
Closed Access | Times Cited: 15
Multiomics characterization implicates PTK7 in ovarian cancer EMT and cell plasticity and offers strategies for therapeutic intervention
Juuli Raivola, Alice Dini, Hanna Karvonen, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 8
Open Access | Times Cited: 10
ROR1-STAT3 signaling contributes to ovarian cancer intra-tumor heterogeneity
Emilia Piki, Alice Dini, Juuli Raivola, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 6
SDCBP Modulates Stemness and Chemoresistance in Head and Neck Squamous Cell Carcinoma through Src Activation
Cristina Mir, Yoelsis García-Mayea, Laia Garcia, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4952-4952
Open Access | Times Cited: 13
Glucocorticoid Receptor and Ovarian Cancer: From Biology to Therapeutic Intervention
Roberto Buonaiuto, Giuseppe Neola, Sabrina Chiara Cecere, et al.
Biomolecules (2023) Vol. 13, Iss. 4, pp. 653-653
Open Access | Times Cited: 5
Functional and clinical significance of ROR1 in lung adenocarcinoma
Giovanna Schiavone, Samantha Epistolio, Vittoria Martin, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 14
Ror1 is expressed inducibly by Notch and hypoxia signaling and regulates stem cell‐like property of glioblastoma cells
Tomohiro Ishikawa, Yasuka Ogura, Kazuhiro Tanaka, et al.
Cancer Science (2022) Vol. 114, Iss. 2, pp. 561-573
Open Access | Times Cited: 8
Antitumor activity of a ROR1 × CD3 bispecific antibody in non-small cell lung cancer
Yi Wang, Yuxi Zhang, Haoyi Sun, et al.
International Immunopharmacology (2023) Vol. 123, pp. 110686-110686
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top